Inhibin-like Material in Stomach Cancer Patients
Author Information
Author(s): S.A. Shanbhag, A.R. Sheth, S.A. Nanivadekar, N.A. Sheth
Primary Institution: Cancer Research Institute, Tata Memorial Centre
Hypothesis
Serum levels of inhibin-like material (ILM) are elevated in patients with carcinoma of the stomach compared to normal individuals and those with chronic superficial gastritis.
Conclusion
Serum ILM concentration is significantly higher in gastric cancer patients, suggesting it may be a useful marker for detecting gastric cancer.
Supporting Evidence
- Serum ILM levels in carcinoma of stomach patients were significantly higher than in normal men and patients with chronic superficial gastritis.
- 62% of patients with carcinoma of stomach showed elevated ILM levels.
- Mean serum ILM concentration in carcinoma patients was 20 times higher than in normal subjects.
Takeaway
Doctors found that people with stomach cancer have much higher levels of a substance called inhibin in their blood compared to healthy people or those with less serious stomach problems.
Methodology
Serum and gastric juice samples were collected from patients and analyzed using radioimmunoassay (RIA) to measure ILM levels.
Limitations
The study had a small sample size and only included male participants.
Participant Demographics
Participants were fasting men aged 30-50 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website